Ocular Genomics
243 Charles Street Boston, MA 02114 Contact us
Diagnostic Testing
Support our research
Explore our labs
Ocular Genomics MENU
Ocular Genomics
  • Meet the Team
  • Services
    • Biobank Core Services
    • Bioinformatics and Statistics Core
    • Functional Genomics (Zebrafish) Core
    • Gene Transfer Vector
      • Rates
      • Order Information
      • Contact Us
    • Genetic Diagnostic Testing Service
      • Pricing
    • Genomics Core Services
      • Additional Genomics Services
      • Sanger Sequencing
      • Array Analysis
      • Next-Generation Sequencing (NGS)
  • Labs
    • Biobank Core
    • Bujakowska Lab
      • Lab Members
      • Publications
    • Comander Lab
      • Lab Members
      • Publications
    • Engle Lab
      • Lab Members
    • Fernandez-Godino Lab
      • Lab Members
      • Macular Degeneration
      • Publications
    • Functional Genomics Core (Zebrafish Facility)
      • Lab Members
    • Genetic Counseling Team
      • Team Members
    • Genomics Core Lab
      • Lab Members
    • Liu Lab
      • Lab Members
      • Publications
      • Projects
    • MEEI Bioinformatics Center (MBC)
      • Lab Members
    • Pierce Lab
      • Lab Members
      • Publications
      • Projects
    • Segrè Lab
      • Selected Publications
    • Vandenberghe Lab
      • Lab Members
    • Wiggs Lab
      • Lab Members
  • News & Publications
    • RETINAL Transcriptome
  • Affiliates
  • Careers
  • Home
  • Uncategorized

Featured Posts

  • Work by Caitlin Collin & Qin Liu highlighted at ARVO 2021 meeting
  • Ground-breaking study to restore vision uses CRISPR technology
  • Licensing Agreement with Biogen to Develop Treatment for Inherited Retinal Disorder

Recent Posts

  • Precision Medicine at Work
  • Work by Caitlin Collin & Qin Liu highlighted at ARVO 2021 meeting
  • Ground-breaking study to restore vision uses CRISPR technology
  • Ocular Genomics Institute Scientists publish large Gene-Wide Association Study of Glaucoma
  • AAVCOVID Vaccine developed by Luk Vandenberghe to start Clinical trials

Archives

  • June 2021
  • May 2021
  • March 2021
  • February 2021
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • June 2020
  • August 2019
  • May 2019
  • April 2019
  • May 2018
  • April 2018
  • March 2018
  • November 2017
  • September 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017

Categories

  • News
  • Publication
  • Uncategorized
Precision Medicine at Work
June 18, 2021

Precision Medicine at work for patients with Inherited Retinal Disorders https://youtu.be/FXdHVi9szb8 Rachel Huckfeldt, MD, PhD of the Inherited Retinal Disorders (IRD) Service and the Ocular Genomics Institute, speaks about the important collaborations between... Read More


Work by Caitlin Collin & Qin Liu highlighted at ARVO 2021 meeting
June 3, 2021

Caitlin CollinQin Liu At the virtual 2021 meeting of the Association for Research in Vision and Ophthalmology (ARVO), Caitlin Collin, PhD, from Mass Eye and Ear (MEE), presented a promising CRISPR/Cas9 gene-editing approach for treating people with autosomal dominant retinitis pigmentosa (adRP) caused by mutations in the gene RP1. The project... Read More


Ground-breaking study to restore vision uses CRISPR technology
May 24, 2021

Eric Pierce MD PhDJason Comander MD PhD Mass Eye and Ear is co-leading a new, revolutionary clinical trial that uses CRISPR gene editing to correct a genetic mutation that leads to a form of blindness caused by Leber congenital amaurosis, an inherited retinal disorder. Clinical trial participant Michael Kalberer is the second person in the... Read More


Ocular Genomics Institute Scientists publish large Gene-Wide Association Study of Glaucoma
March 2, 2021

Janey WiggsAyellet Segre Janey Wiggs, MD, Ph.D., Ocular Genomics Institute Associate Director, Chief of Ophthalmology Clinical Research at Mass Eye and Ear, and the Paul Austin Chandler Professor of Ophthalmology and Vice Chair of Clinical Research at Harvard Medical School, and Ayellet Segre, genetic biostatistician, Ocular Genomics... Read More


AAVCOVID Vaccine developed by Luk Vandenberghe to start Clinical trials
February 10, 2021

Associate OGI Director Luk Vandenberghe and University of Pennsylvania gene therapy head James Wilson said primate safety and efficacy tests have proven promising for their single-dose candidate, targeted for room-temperature storage. The Bill & Melinda Gates Foundation has awarded the researchers up to $2.1 million to move the vaccine... Read More


The Genetics of and Genetic Therapies for Inherited Retinal Degenerations
October 22, 2020

Eric Pierce MD PhD and OGI director participated in the distinguished speaker lecture series organized by the Center For Translational Vision Research at University of California, Irvine in September 2020. You can watch the lecture below. https://youtu.be/uRyAOKuZ928


Rosario Fernandez Godino awarded grant
October 20, 2020

The Global Ophthalmology Awards Program from Bayer has awarded a grant to Rosario Fernandez Godino for her project: Studying the impact of ageing and Bruch’s membrane mechanotransduction in age-related macular degeneration (AMD).This proposal aims to bridge the gaps between normal ageing and RPE/Bruch’s membrane pathology to inform... Read More


2019 Chan Zuckerberg Initiative Seed Network award for the Cell Atlas of the Human Eye
August 16, 2019

Dr. Ayellet Segrè is part of a team of investigators awarded a $2 million grant by the Chan Zuckerberg Initiativeto build a cell atlas of the human eye from birth to old age, as part of a global research effort called the Human Cell Atlas,using single cell RNA-sequencing, and to identify gene expression and regulation specific to different cell... Read More


OGI 2019 Summer Outing
August 16, 2019

On July 10th staff from all the OGI labs gathered for a scavenger hunt in Kendall Square followed by lunch at Flat Top Johnny’s.  Thanks to all who turned out to make this a fun event.    Congratulations to Team 3 for winning the scavenger hunt!   Here are the photos uploaded during... Read More


Stein Innovation Award
August 16, 2019

Eric A. Pierce, MD, PhD, Director of the inherited Disorders Service received the 2019 Stein Innovation Award from Research to Prevent Blindness.  The award provides up to $300,000 over three years to support his research investigating extracellular vesicles as potential biomarkers for retinal degenerations.  


Featured:

Contact Us

243 Charles Street
Boston, MA 02114

Labs

  • Engle Lab
  • Pierce Lab
  • Vandenberghe Lab
  • Wiggs Lab
  • Genomics Core Lab
  • Functional Genomics Core (Zebrafish Facility)
  • MEEI Bioinformatics Center (MBC)

Sitemap

  • Affiliates
  • Careers
  • Meet the Team
  • News & publications
  • Support Our Research
  • Services
  • Privacy
website-boston WebsiteBoston